Clinical Trial Detail

NCT ID NCT02023463
Title Enzalutamide, Radiation Therapy and Hormone Therapy in Treating Patients With Intermediate or High-Risk Prostate Cancer
Recruitment Active, not recruiting
Gender male
Phase Phase I
Variant Requirements No
Sponsors Thomas Jefferson University
Indications

prostate adenocarcinoma

Therapies

Goserelin

Enzalutamide

Leuprolide

Age Groups: adult

No variant requirements are available.